Endocrine Reviews

Papers
(The TQCC of Endocrine Reviews is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Antiobesity Pharmacotherapy for Patients With Genetic Obesity Due to Defects in the Leptin-Melanocortin Pathway634
Papillary Craniopharyngioma: An Integrative and Comprehensive Review298
Correction to: “ER Stress in Cardiometabolic Diseases: From Molecular Mechanisms to Therapeutics”230
DNA Damage and Repair in Thyroid Physiology and Disease226
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies213
Medical Treatment of Acromegaly: Navigating the Present, Shaping the Future185
LGR4: A New Receptor Member in Endocrine and Metabolic Diseases171
Coxsackievirus and Type 1 Diabetes: Diabetogenic Mechanisms and Implications for Prevention128
Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes128
The Molecular Biology of Midgut Neuroendocrine Neoplasms124
Effects of Maternal Vitamin D Supplementation on Childhood Health115
A Critical Assessment of Fasting to Promote Metabolic Health and Longevity115
The Pregnancy-Associated Plasma Protein-A (PAPP-A) Story113
Correction to: “The Congenital and Acquired Mechanisms Implicated in the Etiology of Central Precocious Puberty”108
Update on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies91
Stem Cells and Organs-on-chips: New Promising Technologies for Human Infertility Treatment88
Calcium-sensing receptor regulation of gastrointestinal hormone secretion87
Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward?83
The Biology and Clinical Implications of PCSK776
Recent Advances in the Role of Autophagy in Endocrine-Dependent Tumors71
The Genetic Pathophysiology and Clinical Management of the TADopathy, X-Linked Acrogigantism69
Current Challenges and Future Directions in the Assessment of Glucocorticoid Status68
Estrogen Receptor Signaling in the Immune System67
New and Consolidated Therapeutic Options for Pubertal Induction in Hypogonadism: In-depth Review of the Literature66
Contemporary Biological Insights and Clinical Management of Craniopharyngioma63
Biological and Therapeutic Implications of the Tumor Microenvironment in Pituitary Adenomas63
Correction to: “Imaging of Pheochromocytomas and Paragangliomas”62
Management of Growth Disorders in Puberty: GH, GnRHa, and Aromatase Inhibitors: A Clinical Review60
Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction57
The Metabolic Role and Therapeutic Potential of the Microbiome56
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance55
Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia53
Subtyping of Primary Aldosteronism by Adrenal Venous Sampling51
Glycerol and Glycerol-3-Phosphate: Multifaceted Metabolites in Metabolism, Cancer, and Other Diseases50
The Cortisol Awakening Response: Regulation and Functional Significance50
Imaging of Pheochromocytomas and Paragangliomas48
Adiponectin and Adiponectin Receptors in Atherosclerosis47
Endotrophin, a Key Marker and Driver for Fibroinflammatory Disease46
0.25426197052002